OP White Papers - random

  1. White Paper: Hard Gelatin Capsules Today — And Tomorrow
    4/10/2008
    White Paper: Hard Gelatin Capsules Today — And Tomorrow
  2. Formulation Considerations For Over-Encapsulation Of Clinical Trial Materials In DBcaps® Capsules
    4/5/2007
    White Paper: Formulation Considerations For Over-Encapsulation Of Clinical Trial Materials In DBcaps® Capsules
  3. Bioburden: Addressing Microbial Contamination In Downstream Bioprocessing
    8/30/2017

    A discussion on the risks related to bioburden downstream processing and ways to mitigate them. Topics covered include improvements in raw material, equipment design, and chromatography resin properties.

  4. Buffer Management Solutions For Large-Scale Bioprocessing
    2/1/2018

    How outsourcing and technologies such as in-line conditioning (IC) and in-line dilution (ILD) can help prevent resource constraints, save time, and reduce manufacturing footprint and overall cost in buffer preparation.

  5. Accelerating Lipid-Based Drug Formulation
    7/23/2013

    Formulation scientistsmust develop and validat robust systems that address the challenges posed by increasingly complex drug candidates, in ever shortening time frames.

  6. Drug Safety And Product Protection Driving Blister Packaging Growth

    Trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market. 

  7. The 3 Cs You Should Expect From Your Pharma Service Provider
    9/13/2016

    When asked about the biggest challenges to the pharmaceutical company sponsor-contract service provider relationship, sponsors and service providers offer pretty consistent responses.  

  8. Manufacturing Process Scale-Up For Phase III
    8/15/2017

    The reality is that several manufacturability problems could be brewing that will rain down during Phase III and cause costly delays, no matter how skilled the product and process may be.

  9. Customizing The Cold Chain

    With things “heating up” in terms of more diverse temperature demands, the industry is moving away from the term cold chain, and we’ll start to see more references to the more inclusive temperature-controlled transport.

  10. Unlocking The Potential For Efficiency In Downstream Bioprocesses
    6/16/2016

    In the bioprocessing industry, in order to make full use of upstream advances in an efficient manner, it is essential that downstream processes are intensified.